caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619121621

Mark DicksonM.D.

PRACTICEMEMORIAL SLOAN-KETTERING CANCER CENTERSee all providers at this practice →
Hematology-OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
170
Unique beneficiaries
—
Total services
357
Distinct HCPCS
4
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — below median (cohort median 883).
REFERRAL NETWORK

Where Mark Dickson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Sandra Dangelo
Medical Oncology · New York, NY
21133
Mary Keohan
Hematology-Oncology · New York, NY
21253
Robert Lefkowitz
Diagnostic Radiology · New York, NY
20112
Samuel Singer
Surgical Oncology · New York, NY
18165
MIRONOV, SVETLANA1653
Howard Weinstein
Cardiology · New York, NY
1364
Aimee Crago
Surgical Oncology · New York, NY
1266
Michael Baum
Cardiology · New York, NY
1255
Mark Bluth
Diagnostic Radiology · Commack, NY
1139
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
31
Beneficiaries
—
Total drug cost
$260K
Distinct drugs
2
Brand share
54.8%
Top prescribed drugs
Palbociclib17 claims
Oxycodone Hcl14 claims
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.